Skip to main navigation
Skip to search
Skip to main content
University of Dundee Discovery Portal Home
Search content at University of Dundee Discovery Portal
Home
Profiles
Research units
Research Outputs
Projects
Datasets
Theses
Activity
Press/Media
Research Facilities
Prizes
Potential role of non-insulin adjunct therapy in Type 1 diabetes
P. George
,
R J McCrimmon
Research output
:
Contribution to journal
›
Article
›
peer-review
40
Link opens in a new tab
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Potential role of non-insulin adjunct therapy in Type 1 diabetes'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Type I Diabetes
100%
Type 1 Diabetes Mellitus (T1DM)
100%
Adjunct Therapy
100%
Non-insulin
100%
C-peptide
25%
Intensive Insulin Therapy
12%
Insulin Therapy
12%
Apoptosis
12%
Multicenter Randomized Controlled Trial
12%
Effective Approach
12%
Insulin
12%
Diabetic
12%
Metformin
12%
Leptin
12%
Routine Clinical Practice
12%
Pharmacodynamics
12%
Cell Mass
12%
Glucose Homeostasis
12%
Newly Diagnosed
12%
Physiological Processes
12%
Hemoglobin A1c (HbA1c)
12%
Macrovascular Disease
12%
Glucose Control
12%
Alpha Cell
12%
Diabetes UK
12%
Clinical Trial Data
12%
Endogenous Cells
12%
Dipeptidyl peptidase-4 (DPP-4)
12%
Co-therapy
12%
Physiological Disturbances
12%
Glucagon-like
12%
Postprandial State
12%
Insulin Delivery Systems
12%
Glycemic Targets
12%
Cell Destruction
12%
Disease Reduction
12%
Postprandial Glucose Excursion
12%
Glucose Variability
12%
Pramlintide
12%
Uncontrolled Trial
12%
Glucagon Release
12%
Modern Management
12%
Medicine and Dentistry
Insulin Dependent Diabetes Mellitus
100%
Adjuvant Therapy
100%
Insulin
100%
Glucose
37%
Insulin Treatment
25%
C-Peptide
25%
Randomized Controlled Trial
12%
Programmed Cell Death
12%
Clinical Trial
12%
Glycon
12%
Glucose Homeostasis
12%
Leptin
12%
Glycemic
12%
Postprandial State
12%
Body Weight
12%
Pharmacodynamics
12%
Macrovascular Disease
12%
Diabetes UK
12%
Physiological Process
12%
Glucagon Release
12%
Cell Destruction
12%
Glucagon-Like Peptide-1 Agonist
12%
Pramlintide
12%
Dipeptidyl Peptidase-4 Inhibitor
12%